Finance

Lists
Outlook: 50.0% bullish·15.4% bearish
Go to analysis
SYK:NYSE
Stryker Corp
US$ २९४.६६
+०.४९%
(+१.४३) 1D
US$ २९५.००
+०.१२% (+०.३४)
After hours
Closed: अक्टोबर १६, १६:०२:०४ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for SYK...
Open
US$ २९५.८९
High
US$ २९९.६७
Low
US$ २९३.७५
Mkt. cap
१.१३ खरब
Avg. vol.
२९.३३ लाख
Volume
३३.७७ लाख
Dividend
१.१९%
Quarterly dividend
US$ ०.८८
Ex-dividend date
२०२६ सेप्टेम्बर ३०
P/E ratio
३०.५३
52-wk high
US$ ३९२.५५
52-wk low
US$ २६७.००
EPS
US$ ९.६५
Beta
०.७७
Shares outstanding
३८.३६ करोड
No. of employees
५६ हजार
Open
US$ २९५.८९
High
US$ २९९.६७
Low
US$ २९३.७५
Mkt. cap
१.१३ खरब
Avg. vol.
२९.३३ लाख
Volume
३३.७७ लाख
Dividend
१.१९%
Quarterly dividend
US$ ०.८८
Ex-dividend date
२०२६ सेप्टेम्बर ३०
P/E ratio
३०.५३
52-wk high
US$ ३९२.५५
52-wk low
US$ २६७.००
EPS
US$ ९.६५
Beta
०.७७
Shares outstanding
३८.३६ करोड
No. of employees
५६ हजार
News stories
From web sources and news partners
Profile
Stryker Corporation is an American multinational medical technologies corporation based in Portage, Michigan, United States. The company's products are used for medical surgery and neurotechnology, which include surgical equipment, patient and caregiver safety technologies, endoscopy systems, and patient handling, emergency medical equipment, and intensive care disposable products, as well as neurosurgical, neurovascular and oral and maxillofacial surgery implant products; and orthopedic surgery, which includes implants used in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries. Stryker's products are sold in over 75 countries and are used by 150 million patients annually. In 2024, 75% of the company's revenues came from the United States. The company is ranked 195th on the Fortune 500 and 331st on the Forbes Global 2000. Wikipedia
About Stryker Corp
CEOKevin A. Lobo
Employees५६ हजार
Founded१९४१
Headquartersकालामाजो, मिचिगन, संयुक्त राज्य अमेरिका
Sector-
Analyst ratings
Based on 20 analysts giving stock ratings to SYK in the past 3 months
Strong buy
Buy
18
Hold
2
Sell
0
12-month forecast
Based on 20 Wall Street analysts offering 12 month price targets for SYK in the last 3 months.
Highest
Current US$ २९४.६६
US$ ४२०.०० (+४२.५४%)
Average
US$ ३६४.७२ (+२३.७८%)
Lowest
US$ २९८.०० (+१.१३%)
Analyst
Recommendation
Action
Price target
Projected
Date
Vik Chopra
BMO Capital
Buy
Maintained
US$ ३१७.००
+७.६%
10/12/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
US$ ३८५.००
+३०.७%
10/13/2026
Christopher Pasquale
Barclays
Buy
Maintained
US$ ३७५.००
+२७.३%
10/13/2026
Ryan Zimmerman
BTIG
Buy
Maintained
US$ ३१६.००
+७.२%
10/12/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
US$ ३५३.००
+१९.८%
10/12/2026
Joanne Wuensch
Citi
Buy
Maintained
-
-
10/07/2026
Travis Steed
Bank of America Securities
Buy
Maintained
US$ ३८०.००
+२९%
10/06/2026
Matt Miksic
Barclays
Buy
Maintained
US$ ३७५.००
+२७.३%
10/07/2026
Richard Newitter
Truist Financial
Hold
Maintained
US$ ३१०.००
+५.२%
10/06/2026
Michael Matson
Needham
Buy
Maintained
US$ ४१८.००
+४१.९%
10/06/2026
Kendall Au
RBC Capital
Buy
Maintained
US$ ४२०.००
+४२.५%
10/01/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
US$ ३३०.००
+१२%
09/30/2026
Matthew Taylor
Jefferies
Buy
Maintained
US$ ४०५.००
+३७.४%
09/22/2026
Mathew Blackman
TD Cowen
Hold
Reiterated
US$ २९८.००
+१.१%
09/22/2026
William Plovanic
Canaccord Genuity
Buy
Reiterated
US$ ३८५.००
+३०.७%
09/18/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
US$ ४२०.००
+४२.५%
09/16/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
US$ ३४८.००
+१८.१%
09/16/2026
Steven Lichtman
William Blair
Buy
Reiterated
-
-
09/09/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
US$ ३५०.००
+१८.८%
08/04/2026
David Turkaly
Citizens JMP
Buy
Maintained
US$ ४००.००
+३५.७%
08/03/2026
Jayson Bedford
Raymond James
Buy
Maintained
US$ ३७०.००
+२५.६%
07/31/2026
Matthew O'Brien
Piper Sandler
Buy
Maintained
US$ ३९०.००
+३२.४%
07/31/2026
Patrick Wood
UBS
Buy
Upgraded
US$ ४००.००
+३५.७%
07/28/2026
David Toung
Argus Research
Buy
Reiterated
US$ ३७०.००
+२५.६%
07/09/2026
Unknown Analyst
Wells Fargo
Buy
Maintained
US$ ४१८.००
+४१.९%
07/08/2026
Unknown Analyst
BMO Capital
Buy
Initiated
US$ ३६९.००
+२५.२%
07/09/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$ ३५०.००
+१८.८%
07/06/2026
David Roman
Goldman Sachs
Hold
Maintained
US$ ३६१.००
+२२.५%
05/01/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
US$ ३८५.००
+३०.७%
05/01/2026
Pito Chickering
Deutsche Bank
Hold
Maintained
US$ ३१५.००
+६.९%
05/01/2026
Lee Hambright
Bernstein
Buy
Maintained
US$ ४१०.००
+३९.१%
05/01/2026
Nico Chen
DBS
Buy
Maintained
US$ ४५०.००
+५२.७%
03/18/2026
Danielle Antalffy
UBS
Hold
Reiterated
US$ ३८०.००
+२९%
03/17/2026
Unknown Analyst
Jefferies
Buy
Maintained
US$ ४६५.००
+५७.८%
03/05/2026
Next call १३ दिनमा
अक्टोबर २९, बिहि, २२:३०
Fiscal period
Q3 2026
- / US$ ३.५३
Revenue / Est. (USD)
- / ६.६२ अरब
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
६.०६ अरब
७.१७ अरब
६.०२ अरब
६.५९ अरब
Cost of goods sold
२.१२ अरब
२.४९ अरब
२.१९ अरब
२.०८ अरब
Cost of revenue
२.१२ अरब
२.४९ अरब
२.१९ अरब
२.०८ अरब
Research and development expenses
४०.९० करोड
३८.८० करोड
४०.९० करोड
४२.९० करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
१.९९ अरब
२.१५ अरब
२.१६ अरब
२.१३ अरब
Operating expense
२.५८ अरब
२.७२ अरब
२.७५ अरब
२.७३ अरब
Total operating expenses
४.७१ अरब
५.२२ अरब
४.९५ अरब
४.८१ अरब
Operating income
१.३५ अरब
१.९५ अरब
१.०७ अरब
१.७८ अरब
Other non operating income
-१३.८० करोड
४२.०० करोड
१.९० करोड
१०.०० लाख
EBT including unusual items
१.०३ अरब
१.७० अरब
८५.०० करोड
१.५६ अरब
EBT excluding unusual items
१.२५ अरब
१.८१ अरब
९८.७० करोड
१.६८ अरब
Income tax expense
१७.०० करोड
८५.६० करोड
१०.५० करोड
२८.८० करोड
Effective tax rate
१६.५२%
५०.२१%
१२.३५%
१८.४१%
Other operating expenses
-
-
-
-
Net income
८५.९० करोड
८४.९० करोड
७४.५० करोड
१.२८ अरब
Net profit margin
१४.१८%
११.८४%
१२.३८%
१९.३७%
Earnings per share
३.१९
४.४७
२.६०
३.६९
Interest and investment income
२.८० करोड
३.१० करोड
३.४० करोड
२.६० करोड
Interest expense
-
-६०.७० करोड
-१४.८० करोड
-१४.१० करोड
Net interest expenses
२.८० करोड
-५७.६० करोड
-११.४० करोड
-११.५० करोड
Depreciation and amortization charges
-
-
-
-
EBITDA
१.६६ अरब
२.२७ अरब
१.३७ अरब
२.०८ अरब
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू